ATG2B levels were significantly elevated in EBV-positive NPC compared to healthy controls (p = 0.017), but the difference compared to EBV-negative NPC was not significant (p = 0.19) (Figure 1). Here, ATG2B is linked to nasopharyngeal carcinoma.